Author:
Niu Beidi,Ji Shuyi,Zhao Shi,Lei Hao
Abstract
AbstractBecause of the fading immunity to COVID-19 and continuous evolution of the SARS-CoV-2 Omicron variants, the next epidemic wave of COVID-19 is inevitable. The Omicron variant has been the cause of several waves of the COVID-19 epidemics in the majority of countries. Thus, lessons from other countries may provide guidance regarding the timing and magnitude of the next COVID-19 wave of the pandemic in China. In this study, the COVID-19 surveillance data from 189 countries that experienced two or more waves of the SARS-CoV-2 Omicron variant were analysed. The median peak timing between the first and second/third waves of the SARS-CoV-2 Omicron variant was 164/243 days. The peaks of the second and third waves were much lower than that of the first wave. The median relative peaks of the second and third compared with the first waves were 14.5% and 11.2%, respectively. The time window between the peak timings of the first and second waves showed no significant rank correlation with the five socioeconomic factors included in this study. However, the relative peak of the second wave increased significantly with gross domestic product per capita (P<0.001), urbanisation rate (P=0.003), population density (P=0.007), and proportion of older adults >65 years (P<0.001), although decreased significantly with the proportion of 0-14 teenagers (P<0.001). In summary, the historical situations and progression of COVID-19 outbreaks in other countries may inform the risk assessment of incoming outbreaks in mainland China; however, the timing and magnitude of the next COVID-19 wave may also be influenced by several unknown factors, including rapid viral evaluation of SARS-CoV-2
Publisher
Cold Spring Harbor Laboratory
Reference23 articles.
1. 全国新型冠状病毒感染诊疗和监测数据概述(2022 年 12 月 9 日至 2023 年 1 6708 23 日) [EB/OL].2023[2023-1-25]. https://weekly.chinacdc.cn/fileCCDCW/cms/news/info/upload/ccdcw-surveillance-202212-202301-cn.pdf
2. Willyard C. How quickly does COVID immunity fade? What scientists know. Nature, 2023.
3. Cao Y , Jian F , Wang J , et al. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature, 2022: 1–3.
4. Bobrovitz N , Ware H , Ma X , et al. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression. The Lancet Infectious Diseases, 2023.
5. World Bank. World Bank Open Data. 28 February, 2023. Available at: https://data.worldbank.org.cn/.